Allianz Asset Management
SRRA

Allianz Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Allianz Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,200
Closed -$561K – 2223
2022
Q2 		$561K Buy
+10,200
New +$535K ﹤0.01% 1866
2018
Q3 		– Sell
-419
Closed -$50K – 2763
2018
Q2 		$50K Hold
419
– – ﹤0.01% 2602
2018
Q1 		$35K Buy
+419
New +$47.5K ﹤0.01% 2608

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Allianz Asset Management's SRRA Position: Q3 2022 in Review

Allianz Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 10,200 shares — an estimated $561K sold.

Allianz Asset Management first reported a position in SRRA in Q1 2018 and held it in 3 quarters. The position peaked at $561K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Allianz Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Allianz Asset Management sold 10,200 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $561K.
  • Allianz Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • Allianz Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $561K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Allianz Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.